Tobacco smoking in three “left behind” subgroups: indigenous, the rainbow community and people with mental health conditions

Abstract

<jats:sec> <jats:title content-type="abstract-subheading">Purpose</jats:title> <jats:p>This paper aims to investigate the extent to which three subgroups – people with mental health conditions, people belonging to sexual minority and gender groups and Indigenous peoples – have been “left behind” by countries implementing the World Health Organization’s Framework Convention on Tobacco Control.</jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-subheading">Design/methodology/approach</jats:title> <jats:p>A general review of electronic bibliographical databases to provide an overview of smoking prevalence among the three groups and interventions designed specifically to reduce their smoking rates.</jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-subheading">Findings</jats:title> <jats:p>Although explanations and specific rates differ, two trends are consistent across all three groups. First, information reported in the past two decades suggests that smoking prevalence is disproportionately high among people with mental health conditions, and in the rainbow and indigenous communities. Second, most cessation programmes are targeted at majority politically dominant groups, missing opportunities to reduce smoking rates in these minority communities.</jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-subheading">Research limitations/implications</jats:title> <jats:p>There is a general dearth of data preventing detailed analysis. Better data collection efforts are required. Trials to identify effective smoking reduction interventions for marginalised groups are needed.</jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-subheading">Social implications</jats:title> <jats:p>It is socially unjust that these groups are being systematically ignored by tobacco control initiatives. A failure to equitably reduce tobacco harms among all groups across society has contributed to the perceived concentration of smoking in some subgroups. The increasing stigmatisation of people who smoke then adds a marginality, compounding the negative effects associated with belonging to a marginalised group. Ongoing marginalisation of these groups is an important determinant of smoking.</jats:p> </jats:sec> <jats:sec> <jats:title content-type="abstract-subheading">Originality/value</jats:title> <jats:p>Cross-case analysis of neglected subgroups with disproportionately high smoking rates suggests social marginalisation is a shared and important determinant of smoking prevalence.</jats:p> </jats:sec>

Paying lip service to publication ethics: scientific publishing practices and the Foundation for a Smoke-Free World

“…At the time of their publication, seven of the nine mention some affiliation with FSFW. Of the two papers that did not mention FSFW, one is written by authors from CoEHAR 62 and the other 63 by authors from two FSFWfunded institutions (its other 'centre of excellence' in New Zealand), 64 and UK grantee the Centre for Health Research and Education. 65 Between them, these three grantees received US$10.9 million over 2018 and 2019, 24 38 and have US$30.9 million more approved.…”

Overcoming barriers to disseminate effective smoking cessation treatments globally

“…In addition, the paucity of cessation studies on, treatment protocols for and services tailored to the needs of smokers in certain demographics (gender, mental health, LGBTQ, indigenous populations, etc. ), risks widening the health inequality gap (Glover et al, 2020;Solomon, 2020).…”

Addressing Major Health Disparities Related to Coronavirus for People With Behavioral Health Conditions Requires Strength‐Based Capacity Building and Intentional Community Partnership

“…People with serious mental illness (SMI), and those struggling with or who are in recovery from addiction, face greater difficulties securing adequate food, housing, income, social support, and health insurance (Alexander, Stoller, Haffajee, & Saloner, 2020; Becker & Fiellin, 2020; Druss, 2020; Volkow, 2020) and a 20–30 year mortality gap (Colton & Manderscheid, 2006; Olfson, Gerhard, Huang, Crystal, & Stroup, 2015; Ösby, Brandt, Correia, Ekbom, & Sparén, 2001) due to poor access to quality primary care (Aggarwal, Pandurangi, & Smith, 2013; Bradford et al, 2008; Brugha, Wing, & Smith, 1989; Druss, Bradford, Rosenheck, Radford, & Krumholz, 2000; Lord, Malone, & Mitchell, 2010; Nasrallah et al, 2006), metabolic side effects of antipsychotics (Cohn & Sernyak, 2006; Newcomer, 2007; Newcomer & Haupt, 2006), and other social and behavioral factors (Druss, 2007; Parks, Svendsen, Singer, & Foti, 2006; Viron, Zioto, Schweitzer, & Levine, 2014), which increase the risk of medical conditions such as cardiovascular disease and diabetes (Saha, Chant, & McGrath, 2007; Suetani & Whiteford, 2015). Smoking and vaping are more common among lower‐income communities and people with mental health conditions (Al‐Hamdani, Hopkins, & Park, 2020; Glover, Patwardhan, & Selket, 2020). People who are homeless already face higher risk of mortality (O'Connell, 2005), chronic medical conditions (Koh et al, 2020), mental health and substance use problems (Lebrun‐Harris et al, 2013), and poor health care access (Moore & Rosenheck, 2016).…”